{{Rsnum
|rsid=1712790
|Chromosome=11
|position=114750747
|Orientation=plus
|GMAF=0.4063
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 33.0 | 44.6 | 22.3
| HCB | 24.1 | 54.7 | 21.2
| JPT | 27.4 | 51.3 | 21.2
| YRI | 1.4 | 16.3 | 82.3
| ASW | 3.6 | 36.4 | 60.0
| CHB | 24.1 | 54.7 | 21.2
| CHD | 33.0 | 45.0 | 22.0
| GIH | 34.7 | 51.5 | 13.9
| LWK | 1.9 | 18.9 | 79.2
| MEX | 15.5 | 46.6 | 37.9
| MKK | 9.9 | 28.9 | 61.2
| TSI | 24.5 | 52.0 | 23.5
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs1712790
|PubMedID=17903292
|Condition=Urinary albumin excretion
|Gene=FAM55B
|Risk Allele=
|pValue=2.00E-006
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs1712790
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:17903292; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study (Initial Sample Size: 810-1,010 individuals depending on measure (Framingham; Replication Sample Size: NR). This variant is associated with Urinary albumin excretion.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356365
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1712790
|overall_frequency_n=56
|overall_frequency_d=128
|overall_frequency=0.4375
|n_genomes=37
|n_genomes_annotated=0
|n_haplomes=49
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}